Advocates Lobbied Congress for Cancer Research Funding
Over 750 advocates visited Capitol Hill to push for increased funding and improved clinical trial access.
Updated on Sept. 28, 2026 in Cancer
Live Poll
Should the federal government prioritize increased spending for cancer research and prevention programs?
Advocates including Mercy Campos met with congressional staff to urge increased federal support for cancer research and prevention. The group specifically highlighted the importance of the Clinical Trial Modernization Act.
Why it matters
The effort aims to ensure that medical research remains a national priority and to bridge critical gaps in clinical trial access for underrepresented populations. Persistent funding is seen as a key driver in sustaining the long-term decline in mortality rates.
Federal cancer research funding has contributed to a 34% decline in mortality rates over the past 30 years. More than 750 advocates participated in recent lobbying efforts on Capitol Hill.
The players
Mercy Campos
She is an advocate from Fontana who met with staff for Representative Norma Torres.
American Cancer Society Cancer Action Network
The organization is the nonpartisan advocacy affiliate of the American Cancer Society that hosted the leadership summit.
Norma Torres
She serves as a member of the United States House of Representatives representing California.
The details
Advocates participated in a Leadership Summit and Lobby Day hosted by the American Cancer Society Cancer Action Network. The proposed Clinical Trial Modernization Act is designed to create new mechanisms that increase trial participation for patients facing geographic and income-based barriers.
Timeline
September 2026: Advocates visited Capitol Hill for Lobby Day events.
The Big Picture
The proposed Clinical Trial Modernization Act represents a shift in national health strategy to standardize medical research participation across the United States. This move follows a decades-long pattern of prioritizing research funding to improve patient outcomes.
Patients may eventually see improved access to clinical trials regardless of their geographic location or income level. These policy changes are intended to streamline treatment options and broaden participation in experimental therapies.
The takeaway
Advocacy continues to play a vital role in maintaining the momentum of life-saving medical research. Citizens interested in health policy can monitor future legislative progress regarding trial accessibility.
Further reading
Learn more about the latest developments in the field by visiting our Cancer section.
Source note: This article includes information reported by Inland Empire Community News.
Live Poll
Should the federal government prioritize increased spending for cancer research and prevention programs?
